Drug Channels Archive for March, 2023


Click a link below to view the mailing archive as if it had been sent to you.

2023-03-31 07:47Drug Channels - Brand-Name Drug Prices Fell for the Fifth Consecutive Year—And Plummeted After Adjusting for Inflation (rerun)
2023-03-30 07:47Drug Channels - The Warped Incentives Behind Amgen's Humira Biosimilar Pricing–And What We Can Learn from Semglee and Repatha (rerun)
2023-03-29 07:48Drug Channels - CVS, Walgreens, and Walmart Keep Position in 2023 Part D Preferred Networks—While Kroger Bails Over its Express Scripts Blowup (rerun)
2023-03-28 07:47Drug Channels - The Big Three PBMs' 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars (rerun)
2023-03-27 07:47Drug Channels - Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)
2023-03-24 07:47Drug Channels - Winning the Race for Patient Access: Identifying Copay Accumulator Impact
2023-03-23 07:47Discount Cards, Cost-Plus Pharmacies, and PBMs: Join me next Friday for a new live video webinar
2023-03-21 07:47Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists
2023-03-20 07:47Drug Channels - Informa Connect's Annual Life Sciences Commercial Contracts & Chargebacks Congress
2023-03-17 07:47Drug Channels - It's Not All Bad News: Data Shows There's a Collaborative Future for 340B
2023-03-14 07:47Drug Channels - NOW AVAILABLE: The 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
2023-03-13 07:47Drug Channels - Informa Connect's Medicaid & Government Pricing Congress
2023-03-10 07:47Drug Channels - Taking A Technology-First Approach In Your Affordability Program
2023-03-08 08:07Drug Channels - The Top 15 U.S. Pharmacies of 2022: Market Shares and Revenues at the Biggest Companies
2023-03-07 07:47Drug Channels - Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook (NEW Live Video Webinar)
2023-03-06 07:47Drug Channels - Informa Connect's Drug Pricing Transparency Congress
2023-03-03 07:47Drug Channels - What a Technology-First Approach Really Means for Your Patient Support Program

 

<< Archive IndexSubscribe >>